CNS & Neurological Disorders - Drug Targets

Formerly Current Drug Targets - CNS & Neurological Disorders

Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 11 Issue: 5, August 2012



Conference Report (The XVth International Symposium of Brain Edema and Cellular Injury)

Volume:11   Issue: 5
Pp: 491-493
Hari S. Sharma and Aruna Sharma
DOI: 10.2174/187152712801661202
Published on: 29 June, 2012



Commentary Research Highlights (Amyloid β-Peptide and Alzheimer’s Disease: It’s All the RAGE)

Volume:11   Issue: 5
Pp: 494-494
Stephen D. Skaper
DOI: 10.2174/187152712801661275
Published on: 29 June, 2012



Editorial [Hot Topic: Multiple Sclerosis – From Bench to Bedside (Guest Editors: Sandra Amor and David Baker)] free to download

Volume:11   Issue: 5
Pp: 495-496
David Baker and Sandra Amor
DOI: 10.2174/187152712801661211
Published on: 29 June, 2012

Recent Gains in Clinical Multiple Sclerosis Research

Volume:11   Issue: 5
Pp: 497-505
T. F. Runia, E. D. van Pelt-Gravesteijn and R. Q. Hintzen
DOI: 10.2174/187152712801661239
Published on: 29 June, 2012

Pathology of Multiple Sclerosis open access plus

Volume:11   Issue: 5
Pp: 506-517
Markus Kipp, Paul van der Valk and Sandra Amor
DOI: 10.2174/187152712801661248
Published on: 29 June, 2012

Optical Coherence Tomography Detection of Neurodegeneration in Multiple Sclerosis

Volume:11   Issue: 5
Pp: 518-527
Katie Lidster and David Baker
DOI: 10.2174/187152712801661185
Published on: 29 June, 2012

Viruses and Multiple Sclerosis open access plus

Volume:11   Issue: 5
Pp: 528-544
Jussi Oskari Virtanen and Steve Jacobson
DOI: 10.2174/187152712801661220
Published on: 29 June, 2012

Multiple Sclerosis: Risk Factors and their Interactions

Volume:11   Issue: 5
Pp: 545-555
Giulio Disanto, Julia M. Morahan and Sreeram V. Ramagopalan
DOI: 10.2174/187152712801661266
Published on: 29 June, 2012

Mechanisms in the Development of Multiple Sclerosis Lesions: Reconciling Autoimmune and Neurodegenerative Factors

Volume:11   Issue: 5
Pp: 556-569
Johannes M. van Noort, David Baker and Sandra Amor
DOI: 10.2174/187152712801661293
Published on: 29 June, 2012

In Vitro and In Vivo Models of Multiple Sclerosis

Volume:11   Issue: 5
Pp: 570-588
Baukje J. van der Star, Daphne Y.S. Vogel, Markus Kipp, Fabiola Puentes, David Baker and Sandra Amor
DOI: 10.2174/187152712801661284
Published on: 29 June, 2012

Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis

Volume:11   Issue: 5
Pp: 589-597
Graham R. Campbell and Don J. Mahad
DOI: 10.2174/187152712801661194
Published on: 29 June, 2012

Endogeneous Remyelination: Findings in Human Studies

Volume:11   Issue: 5
Pp: 598-609
Markus Kipp, Marion Victor, Gianvito Martino and Robin J.M. Franklin
DOI: 10.2174/187152712801661257
Published on: 29 June, 2012

Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon

Volume:11   Issue: 5
Pp: 610-623
Monica Marta and Gavin Giovannoni
DOI: 10.2174/187152712801661301
Published on: 29 June, 2012

Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System

Volume:11   Issue: 5
Pp: 624-641
Gareth Pryce and David Baker
DOI: 10.2174/187152712801661310
Published on: 29 June, 2012